DCF — NOVANT HEALTH MINT HILL MEDICAL CTR
Enterprise Value: $87.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$87.4M
Enterprise Value
$23.0M
PV of Cash Flows
$64.4M
PV of Terminal Value
$103.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $111.0M | $11.3M | 10.0% | $4.5M | $4.0M |
| Year 2 | $114.3M | $12.8M | 11.0% | $5.4M | $4.5M |
| Year 3 | $117.8M | $14.3M | 12.0% | $6.5M | $4.9M |
| Year 4 | $121.3M | $15.4M | 13.0% | $7.1M | $4.9M |
| Year 5 | $124.9M | $16.1M | 13.0% | $7.6M | $4.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $87.4M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$107.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.09657204767441943
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5